Xeplion

Xeplion is an injectable antipsychotic medication containing paliperidone palmitate, used for managing symptoms of schizophrenia and related conditions. This extended-release formulation provides steady medication levels over time. It is administered by a healthcare professional via intramuscular injection.

Xeplion is primarily used to treat schizophrenia, a mental health condition that causes symptoms like hallucinations, delusions, and disordered thinking. It may also be prescribed for schizoaffective disorder, a condition that combines schizophrenia symptoms with mood disorder elements. The medication helps stabilize mood and reduce disruptive behaviors associated with these conditions.

Xeplion works gradually to help manage symptoms by balancing certain chemicals in the brain. Patients may notice improved focus, reduced agitation, and a calmer mental state over time. The extended-release nature means effects are sustained between doses, supporting consistent symptom control.

Xeplion should be stored at room temperature and protected from light. It is important to follow the prescribed injection schedule and attend all medical appointments. Patients should inform their healthcare provider about any allergies, current medications, or medical history before starting treatment.

Xeplion may interact with other medications that affect the central nervous system, such as sedatives or alcohol, potentially increasing drowsiness. It can also interact with drugs that influence liver enzymes, like certain antidepressants or antifungals, which may alter its effectiveness. Always disclose all medications to your healthcare provider.